Former CR Bard executives found guilty
This article was originally published in Clinica
Three former CR Bard executives were found guilty on August 24th of conspiring to defraud the US FDA in connection with faulty catheters. Acting US Attorney Jonathan Chiel said that evidence presented during the eight-week trial demonstrated that from 1987 to early 1990, Bard - at the direction of the three defendants - unlawfully sold and distributed heart catheters which had not been approved by the FDA for human use. Sentencing is scheduled for November 1st: each defendant faces up to five years' imprisonment and a fine of $250,000.